OncoMatch/Clinical Trials/NCT03925662
Mebendazole as Adjuvant Treatment for Colon Cancer
Is NCT03925662 recruiting? Yes, currently enrolling (Jun 2026). This Phase 3 trial studies multiple treatments including Folfox with avastin and Mebendazole for colorectal cancer.
Treatment: Folfox with avastin · Mebendazole — mebendazole treating colon cancer
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Folfox with avastinMebendazole
Cancer type
Colorectal Cancer
Disease stage
Required: Stage IV
Colorectal cancer stage 4.
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT03925662 currently recruiting?
Yes, this trial is currently recruiting patients.
What disease stage is eligible?
Stage IV is required.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages